This Week in Hearing

Rock guitar legend Paul Gilbert (Mr. Big, Racer X) joins host Shari Eberts to share his personal journey with hearing loss and how it has shaped his life, both on and off the stage. He opens up about the challenges of understanding speech compared to music, the role of hearing aids in his daily life, and how he has learned

What does it really take to keep a private audiology practice running smoothly? In this episode, Operations Manager Carla Taghvaei of A&A Audiology in Scottsdale, Arizona, offers a behind-the-scenes look at the daily challenges and rewards of managing a growing clinic. Carla shares how her practice organizes patient scheduling, handles insurance and third-party billing, manages staff training, and creates a

Comedian D.J. Demers joins Gael Hannan to explore the intersection of humor and hearing loss. Known for his appearances on America’s Got Talent, late-night talk shows, and his Canadian sitcom One More Time, Demers has built a career making audiences laugh while also normalizing conversations about hearing aids and everyday challenges of hearing loss. In this conversation, he shares how

Can regenerative medicine move beyond managing symptoms to actually restore natural hearing? Brian Taylor speaks with Simon Chandler, CEO of Rinri Therapeutics, about the company’s pioneering cell therapy for hearing loss. They discuss Rincell-1, Rinri’s first-in-human clinical trial, and how regenerative medicine could complement or even surpass today’s treatments like hearing aids and cochlear implants. The conversation also explores Rinri’s

What if a regenerative therapy could not only halt sudden hearing loss but also help the inner ear repair itself? Dr. Reimar Schlingensiepen, CEO of Berlin-based biotech AudioCure, joins Brian Taylor to discuss AC102, the company’s lead compound now in Phase 2 clinical trials for sudden sensorineural hearing loss. With limited treatment options available today, the drug is being closely

Madison Levine sits down with Dave Kemp to share her journey from founding a private practice to shaping it into a clinic that bridges hearing care with the wider healthcare system, emphasizing the role of hearing in cognition and aging well. She discusses her recent TEDx talk, the importance of physician and patient education, and how hearing care professionals can

Phonak has introduced the Virto R Infinio, its first fully rechargeable custom in-the-ear hearing aid. Built on the Infinio platform, Virto R offers a deeply recessed, discreet fit while delivering the same advanced performance as Phonak’s behind-the-ear models. Key features include RightFit technology for personalized acoustics, biometric calibration for optimized directionality, and AutoSense OS 7 trained on 18x more real-life

For the first time, optical coherence tomography (OCT) is being used to study the human inner ear directly in patients. In this follow-up conversation, Dr. John Oghalai, Professor and Chair of the Caruso Department of Otolaryngology at USC, shares the latest advances in this groundbreaking research. Dr. Oghalai describes how his team has transitioned from animal studies to human imaging,

What if a cochlear implant could adapt and improve throughout a patient’s lifetime? Hearing health advocate and author Gael Hannan sits down with Brendan Murray, Vice President of CI Product Portfolio at Cochlear, to discuss the launch of the Cochlear™ Nucleus® Nexa™ System. The Nexa is the first cochlear implant platform with upgradeable firmware, allowing recipients to benefit from future

ReSound has introduced the Enzo IA, its newest super-power hearing aid built for people with severe-to-profound hearing loss. Smaller and rechargeable, Enzo IA offers up to 28 hours of battery life while delivering powerful gain without feedback. It also brings advanced hearing-in-noise performance through the new Clear Focus beamforming system, along with Auracast™ compatibility for next-generation streaming in public and